# Study of Recovery of Intestinal CD4+ and Th17 T Cells in HIV-infected Individuals on Short-term Antiretroviral Therapy

> **NCT02097381** · NA · UNKNOWN · sponsor: **University of Roma La Sapienza** · enrollment: 10 (actual)

## Conditions studied

- HIV Infection

## Interventions

- **DRUG:** Tenofovir-Emtricitabine plus Lopinavir/Ritonavir or Darunavir/Ritonavir

## Key facts

- **NCT ID:** NCT02097381
- **Lead sponsor:** University of Roma La Sapienza
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-04
- **Primary completion:** 2014-03
- **Final completion:** 2014-12
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2014-03-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02097381

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02097381, "Study of Recovery of Intestinal CD4+ and Th17 T Cells in HIV-infected Individuals on Short-term Antiretroviral Therapy". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02097381. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
